Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Thrombosis and Thrombolysis|April 24, 2020
Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the prevention of venous thromboembolismIsabel Reinecke, Alexander Solms, Stefan Willmann, et al.
Journal of Thrombosis and Thrombolysis|April 24, 2020
Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in patients with non-valvular atrial fibrillationLiping Zhang, Xiaoyu Yan, Keith A A Fox, et al.
Drugs in R&D|August 20, 2024
Damoctocog Alfa Pegol, a PEGylated B-domain Deleted Recombinant Extended Half-life Factor VIII for the Treatment of Hemophilia A: A Product ReviewMark T Reding, Shadan Lalezari, Gili Kenet, et al.
Journal of Thrombosis and Thrombolysis|April 24, 2020
Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the treatment of venous thromboembolismAlexander Solms, Stefan Willmann, Isabel Reinecke, et al.
Drugs in R&D|July 9, 2023
Hepatotoxicity of AKR1C3 Inhibitor BAY1128688: Findings from an Early Terminated Phase IIa Trial for the Treatment of EndometriosisJan Hilpert, Esther Groettrup-Wolfers, Hristiyan Kosturski, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 4, 2021
PK/PD modeling of FXI antisense oligonucleotides to bridge the dose-FXI activity relation from healthy volunteers to end-stage renal disease patientsStefan Willmann, Eleonora Marostica, Nelleke Snelder, et al.
Kidney International|March 27, 2024
A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysisWolfgang C Winkelmayer, Anthonie W A Lensing, Ravi I Thadhani, et al.
Pageof 3